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ABSTRACT
enign prostatic hyperplasia (BPH) is a 
progressive disease that leads to lower urinary 
tract symptoms (LUTS) with attendant decrease B
in the quality of life in men. It is the commonest 
complain among ageing male population in the 
1
urology clinic . Transurethral resection of the prostate 
(TURP) is the current gold standard for operative 
management of symptomatic BPH and has excellent 
2
long term efficacy .
Monopolar TURP has been available for over ten 
decades globally. Currently there is a gradual shift 
towards bipolar TURP and Holmium enucleation of 
the prostate (HoLEP) due to fear of complications, 
particularly TUR syndrome associated with the 
monopolar TURP. However, bipolar generator and 
high powered holmium laser resectoscpe remain very 
expensive and make the bipolar TURP/HoLEP out of 
reach to majority of our patients. There have been 
numerous technical improvements of TURP 
implemented over the past two decades, including 
video-assisted TURP, continuous flow instruments, 
special loop designs, and modification of high 
frequency generators, have evolved the monopolar 
TURP into a safer operation and makes it superior to 
3
many minimally invasive therapy options .  This study 
seeks to review our experience with monopolar TURP 
with a view to appraising its usefulness and 
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PATIENTS AND METHODS: Records of 42 patients, who underwent monopolar TURP for BPH between 
October, 2013 and September, 2016 were reviewed retrospectively. The data of patients who had undergone 
monopolar TURP, following standardized technique, were retrieved and subjected to statistical analysis.
RESULTS: The mean age of the 42 patients was 67.07±9.38 (range 51 – 86). Those in the age range 60-69 years 
had most of the procedure. The mean prostate volume was 70±23.74 (ml); the mean prostate specific antigen (PSA) 
was 5.32±5.4ng/ml.  All the patients had spinal anaesthesia. The mean intraoperative time was 71.05±19.07 (mins), 
while the mean hospital stay for the patients was 61.14±27.13 (hrs). The mean volume of 5% dextrose-water used 
for irrigation at surgery was 30L. Most of the patients, 33(78.6%) had their catheters removed at 3-5 postoperative 
days. Only, 9(21.4%) had catheter for more than 5 days. The mean weight of resected prostatic chips was 29±9.2g. 
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the age range 60-69 years had most of the procedure.  
Some of the patients also presented with various co-
morbities that were adequately controlled before 
surgery (table 1). 
Table1: Comorbities as seen in the 42 patients who 
had monopolar TURP
The mean prostate volume was 70±23.74ml; the mean 
prostate specific antigen (PSA) was 5.32±5.4ng/ml.  
The indications for the surgery for the patients are as 
shown in table 2.
Table 2: Indications for the Monopolar TURP in the 
42 patients
All the patients had spinal anaesthesia. The mean 
intraoperative time was 71.05±19.07 (mins), while the 
mean hospital stay for the patients was 61.14±27.13 
(hrs). The mean quantity of 5%dextrose-water used for 
irrigation at surgery was 30L. Most of the patients, 
33(78.6%) had their catheters removed at 3-5 
postoperative days. Only, 9(21.4%) had catheter for 
more than 5 days. The mean weight of the resected 
prostatic chips was 29±9.2g. Resected chips specimen 
f r o m  2 ( 4 . 8 % )  p a t i e n t s  t u r n e d  o u t  t o  b e  
adenonocarcinoma and the patients were referred for 
further treatment. The complications observed during 
the surgery and during follow up visits are shown in 
table 3. All patients except 1(2.4%) had satisfactory 
voiding removal of catheter and subsequent follow up 
visits.
complications seen in our patients.
PATIENTS AND METHODS
Records of 42 patients, who underwent monopolar 
TURP for BPH between October, 2013 and September, 
2016 were reviewed retrospectively. Patients were 
thoroughly evaluated and had full blood count, serum 
e lec t ro lytes/urea/creat in ine ,  ches t  X-ray ,  
electrocardiogram (ECG) before surgery. Prostate 
biopsy was also carried out for patient with elevated 
prostate specific antigen (PSA).
Data on patients' demographics, indication for the 
surgery, prostate volume, PSA, operative time, volume 
of irrigation fluid used, intraoperative and 
postoperative complications, duration of surgery, 
duration of postoperative urethral catheterization and 
duration of hospital stay were obtained. Data was 
entered into and analysed using  SPSS®version 22.
Surgical technique
The monopolar TURP was performed under spinal 
anaesthesia with patient in lithotomy position. 
Cystoscopy was first carried out to assess the size and 
configuration of the prostate and to rule out the 
presence of concomitant bladder pathologies such as 
stone, tumour and diverticulum. The surgery was 
performed using size 26Fr rotatable sheath, continuous 
flow resectoscope with active working element (Vega, 
Germany) and DRE ASG-300 electrosurgical unit set at 
140w cutting and 70w coagulation. Irrigation was 
achieved with 5% dextrose-water in 1L bag hung at 
height of 60cm set above the patient's pubic symphysis. 
The patients' urethral meatus were routinely calibrated 
with Clutton dilator up to up to size 28Fr (one size 
larger than the resectoscope sheath) and adequate 
instillation of KY jelly lubricant to allow free passage of 
the resectoscope.
The median, lateral, anterior and apical prostatic 
tissues were resected to the prostatic capsule in 
accordance with the Mauermayer resection technique 
and the prostatic chips evacuated with Boston 
Scientific/Microvasive evacuator. A size 20Fr 3-way 
silicone urethral catheter was inserted after each 
procedure to allow continuous bladder irrigation with 
normal saline.
Intravenous antibiotics were given for 48hrs 
postoperative and subsequently oral antibiotics till 
catheter was removed as prophylaxis.  Postoperative 
analgesia consisted mainly of oral paracetamol. 
RESULTS
A total of 42 patients underwent the monopolar TURP 
for BPH during the period under review. The mean age 
of the patients was 67.07±9.38 (range 51 – 86). Those in 















Total number of patients 42 (100%)
Persistent haematuria  3(7.3%)
Recurrent acute urinary retention  5(11.9%)






Failed medical treatment 
 
9(21.4%)
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Intraoperative complications   
 





























Transurethral resection of the prostate (TURP) due to 
its efficacy is the undisputed gold standard of therapy 
2,7
for patients with LUTS secondary to BPH . The 
durability of the relief of BPH associated LUTS after 
TURP is unsurpassed.
With various technical improvements over the past 
decades TURP though not without complications is a 
safer and more acceptable surgery compared to open 
prostatectomy. Transurethral resection (TUR) 
syndrome one of the more feared and potentially fatal 
complications of monopolar TURP has decreased 
significantly during the last few decades from 3% to 
8,9,10
less than 1% .  Transurethral resection (TUR) 
syndrome occurs when significant hypotonic fluid 
used for irrigation during the monopolar TURP is 
12
absorbed leading to systemic manifestations . It may 
be seen from as early as 15mins after resection starts of 
13
the procedure to up to 24hrs postoperatively . In a 
7
series by Mebust  and colleagues the TUR syndrome 
occurred in 2.0%. Other authors have reported 
15, 16, 17, 18
incidence of 2.8% . We did not observed TUR 
19 
syndrome in our study. Similarly, Ali and his 
colleagues in their large series review of 3589 
monopolar TURP in Turkey did not observe this 
20
complication.  Also, Jen Rassweiler and colleagues in 
a met-analysis of monopolar TURP for two periods: 
early (1979-1994) and recent (2000-2005) found that the 
incidence of TUR syndrome was 1.1% vs. 0.0%. This 
reduction has been attributed to use of video assistance 
in TURP, continuous-flow resectoscope and improved 
surgical technique.
Retrograde ejaculation occurs in majority of patients 
following TURP. Many of our patients (76%) 
complained about retrograde ejaculation.  A meta-
analysis found retrograde ejaculation in 65.4% of 
21
patients . Antegrade ejaculation could be preserved in 
younger patients if necessary by preserving the 
22
bladder neck at resection . Our patients were 
counseled about this complication and those that 
developed the complication expressed concern.
Bleeding requiring blood transfusion is a major 
intraoperative complication during TURP. Only 
1(2.4%) of our patients required blood transfusion due 
to intraoperative bleeding.  This compares with finding 
14
by Mebust  and colleagues in their of 3885 TURP 
where the recorded transfusion rate of 2.5%. 
23
Horninger  and colleagues recorded a transfusion rate 
of 4.2%.
We used 5% dextrose water as irrigation fluid for all the 
procedures.  This fluid is less commonly associated 
22
with TUR syndrome. Yousef  and colleagues in a 
randomized comparison between 5% dextrose-water, 
Table3: Complications observed following 
monopolar TURP for the 42 patients:
DISCUSSION 
Bladder outlet obstruction secondary to BPH can result 
in significant complications including renal failure, 
urinary retention, recurrent urinary tract infection, 
bladder diverticulum; bladder and renal stone as well 
as haematuria. There has been a considerable interest in 
the past decade in the development of medical and 
minimally invasive therapies for BPH. Unfortunately, 
the outcome indicators for these therapies are not as 
4,5
reliable as that of TURP . Patients who choose the 
medical and minimally invasive therapies do so 
because of the reduced adverse events. This trade off of 
risk for efficacy sometimes does not work in favour of 
the patient. In our study patients who had severe LUTS 
or developed complications due to BPH were those 
subjected to the monopolar TURP. The NICE (National 
Institute of Clinical Excellence) guidelines of 2010 for 
4
LUTS due to BPH  in men recommend TURP for severe 
LUTS or when conservative management options are 
not successful. Severe LUTS (40.5%) was the 
commonest reason for the monopolar TURP in our 
review while failed medical treatment (21.4%) was the 
second most common indication for the procedure in 
the review. European Urology Association (EUA) 
6
guidelines for BPH  also identify the bothersome LUTS 
refractory to medical treatment and severe LUTS as the 
common indications for TURP.
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